| Closed |
S1612 |
Older AML |
12/22/2017 |
|
5% |
|
|
| Open |
S1918 |
Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL |
3/19/2021 |
|
23% |
|
|
| Open |
S2012 |
II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab in Patients with Poorly Differentiated Extrapulmonary Small Cell NEC |
12/2/2021 |
|
23% |
|
|
| Closed |
S1800D |
LUNGMAP S1800D: Non-match Sub-Study |
2/15/2022 |
3/10/2023 |
17% |
|
|
| Closed |
SWOG-8014 |
Colchicine in Refractory Chronic Lymphocytic Leukemia |
7/7/1980 |
10/23/1981 |
|
|
|
| Closed |
SWOG-8825 |
Phase I Trial of Intravenous Bolus Melphalan With GM-CSF |
12/15/1988 |
12/1/1990 |
87% |
|
Published
|
| Closed |
SWOG-7960 |
Colchicine in Refractory Hodgkin's Disease, CLL, Lung and Breast Cancer |
2/28/1979 |
7/7/1980 |
|
|
|
| Closed |
SWOG-7863 |
Concurrent Chemotherapy-Radiotherapy of Selected Cancers of the Head and Neck |
5/18/1978 |
10/22/1980 |
|
|
|
| Closed |
SWOG-7864 |
Combined Modality Treatment of Residual Gastric Carcinoma Following Initial Surgery |
4/26/1978 |
10/4/1979 |
|
|
|
| Closed |
SWOG-8903 |
Phase I Trial of Promace-CytoBOM with GM-CSF for Treatment of Non-Hodgkin's Lymphoma |
11/15/1989 |
11/1/1993 |
93% |
|
Published
|
| Closed |
SWOG-9120 |
Investigation of G-CSF and Trans-Retinoic Acid in the Treatment of Myelodysplastic Syndrome, Phase I |
4/1/1993 |
7/1/1995 |
23% |
|
|
| Closed |
SWOG-8902 |
Phase I Trial of Doxorubicin plus Carboplatin with GM-CSF in Patients with Advanced, Previously Treated Cancer |
4/15/1990 |
5/1/1992 |
70% |
|
Published
|
| Closed |
SWOG-8833 |
Phase ll Investigation of Chlorambucil and Fludarabine Monophosphate in Relapsed or Refractory Chronic Lymphocytic Leukemia |
5/15/1989 |
4/15/1991 |
88% |
|
Published
|
| Closed |
SWOG-9112 |
A Phase I Study of the Combination of High Dose Chemotherapy, Granulocytemacrophage Colony Stimulating Factor, and Interleukin-2 |
7/15/1991 |
11/1/1992 |
3% |
|
|
| Closed |
SWOG-8746 |
Phase I Trial of Dose Intensive Chemotherapy Combined with Granulocyte-Macrophage Colony Stimulating Factor in Advanced Breast Cancer |
9/1/1988 |
9/1/1992 |
67% |
|
Published
|
| Closed |
SWOG-8940 |
A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer |
3/1/1990 |
11/1/1992 |
100% |
|
Published
|
| Closed |
S9617 |
A Phase I Study of PSC833 As Chemotherapy – Resistance Modifier in Patients Over Age 55 With Previously Untreated Myeloid Leukemia (AML). |
11/1/1996 |
9/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-8922 |
Phase I Trial of Doxorubicin, DTIC and Ifosfamide with Recombinant Granulocyte-Macrophage Colony Stimulating Factor in Advanced Soft Tissue Sarcomas |
9/15/1990 |
9/15/1992 |
28% |
|
Published
|
| Closed |
SWOG-8801 |
A Study of the Sequential Combination of Recombinant Interferon Gamma (rIFN-y) and Recombinant Interleukin-2 (rIL-2) in Patients with Disseminated Malignant Disease |
10/1/1988 |
1/1/1990 |
100% |
|
Published
|
| Closed |
SWOG-9462 (NABTC-9404) (NCI T94-0034) |
A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy |
7/28/1995 |
8/15/1997 |
90% |
|
|
